Negative regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5

Molecular Endocrinology

Volumn 26, Issue 7, 2012, Pages 1225-1234

  Zhou, Guisheng ^a,b   Liu, Shi He ^a,b   Shahi, Kelly M ^a,b   Wang, Hua ^b   Duan, Xueyan ^b   Lin, Xia ^b   Feng, Xin Hua ^b   Li, Min ^b   Fisher, William E ^b   Demayo, Francesco J ^b   Dawson, David ^a   Charles Brunicardi, F ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CYCLINE; GLUCOSE; HORMONE RECEPTOR STIMULATING AGENT; INSULIN; MESSENGER RNA; RPL 1980; SHORT HAIRPIN RNA; SOMATOSTATIN RECEPTOR 5; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL PROLIFERATION; CELL STRAIN HEK293; CHEMICAL ANALYSIS; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; INSULIN RELEASE; INSULINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; SINGLE NUCLEOTIDE POLYMORPHISM; UBIQUITINATION;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HEK293 CELLS; HOMEODOMAIN PROTEINS; HUMANS; INSULIN; INSULINOMA; MICE; MICE, KNOCKOUT; POLYMORPHISM, SINGLE NUCLEOTIDE; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTORS, SOMATOSTATIN; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SOMATOSTATIN; TRANS-ACTIVATORS; UBIQUITINATION;

MUS;

EID: 84863315719     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1095     Document Type: Article

References (71)

1. Krulich L, Dhariwal AP, McCann SM 1968 Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro. Endocrinology 83:783-790
2. Bodei L, Ferone D, Grana CM, Cremonesi M, Signore A, Dierckx RA, Paganelli G 2009 Peptide receptor therapies in neuroendocrine tumors. J Endocrinol Invest 32:360-369
3. Florio T 2008 Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors. Front Biosci 13:822-840
4. Modlin IM, Pavel M, Kidd M, Gustafsson BI 2010 Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours. Aliment Pharmacol Ther 31: 169-188
5. Pyronnet S, Bousquet C, Najib S, Azar R, Laklai H, Susini C 2008 Antitumor effects of somatostatin. Mol Cell Endocrinol 286:230-237
6. Patel YC 1999 Somatostatin and its receptor family. Front Neu-roendocrinol 20:157-198
7. Strowski MZ, Blake AD 2008 Function and expression of soma-tostatin receptors of the endocrine pancreas. Mol Cell Endocrinol 286:169-179
8. Fagan S, Azizzadeh A, Moldovan S, Ray MK, Adrian TE, Ding X, Coy DH, Brunicardi FC 1998 Insulin secretion is inhibited by subtype five somatostatin receptor in the mouse. Surgery 124:254-259
9. Reubi JC, Horisberger U, Essed CE, Jeekel J, Klijn JG, Lamberts SW 1988 Absence of somatostatin receptors in human exocrine pancreatic adenocarcinomas. Gastroenterology 95:760-763
10. Player A, Gillespie J, Fujii T, Fukuoka J, Dracheva T, Meerzaman D, Hong KM, Curran J, Attoh G, Travis W, Jen J 2003 Identification of TDE2 gene and its expression in non-small cell lung cancer. Int J Cancer 107:238-243
11. Rosenberg L, Lipsett M, Yoon JW, Prentki M, Wang R, Jun HS, Pittenger GL, Taylor-Fishwick D, Vinik AI 2004 A pentadecapep-tide fragment of islet neogenesis-associated protein increases β-cell mass and reverses diabetes in C57BL/6J mice. Ann Surg 240:875-884
12. Zatelli MC, Tagliati F, Taylor JE, Rossi R, Culler MD, Degli Uberti EC 2001 Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line tt. J Clin Endocrinol Metab 86:2161-2169
13. Qiu CZ, Wang C, Huang ZX, Zhu SZ, Wu YY, Qiu JL 2006 Relationship between somatostatin receptor subtype expression and clinicopathology, Ki-67, Bcl-2 and p53 in colorectal cancer. World J Gastroenterol 12:2011-2015
14. Patel SG, Zhou G, Liu SH, Li M, Jeong JW, Demayo FJ, Gingras MC, Gibbs RA, Fisher WE, Brunicardi FC2009 Microarray analysis of somatostatin receptor 5-regulated gene expression profiles in murine pancreas. World J Surg 33:630-637
15. Ohlsson H, Karlsson K, Edlund T 1993 IPF1, a homeodomain-containing transactivator of the insulin gene. EMBO J 12:4251-4259
16. Leonard J, Peers B, Johnson T, Ferreri K, Lee S, Montminy MR 1993 Characterization of somatostatin transactivating factor-1, a novel homeobox factor that stimulates somatostatin expression in pancreatic islet cells. Mol Endocrinol 7:1275-1283
17. Olson LK, Redmon JB, Towle HC, Robertson RP 1993 Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription and alters binding of insulin gene regulatory protein. J Clin Invest 92:514-519
18. Miller CP, McGehee Jr RE, Habener JF 1994 IDX-1: a new home-odomain transcription factor expressed in rat pancreatic islets and duodenum that transactivates the somatostatin gene. EMBO J 13: 1145-1156
19. Marshak S, Totary H, Cerasi E, Melloul D 1996 Purification of the β-cell glucose-sensitive factor that transactivates the insulin gene differentially in normal and transformed islet cells. Proc Natl Acad Sci USA 93:15057-15062
20. Macfarlane WM, Smith SB, James RF, Clifton AD, Doza YN, Cohen P, Docherty K 1997 The p38/reactivating kinase mitogen-acti-vated protein kinase cascade mediates the activation of the transcription factor insulin upstream factor 1 and insulin gene transcription by high glucose in pancreatic β-cells. J Biol Chem 272:20936-20944
21. Khoo C, Yang J, Weinrott SA, Kaestner KH, Naji A, Schug J, Stoffers DA 2012 Research resource: the pdx1 cistrome of pancreatic islets. Mol Endocrinol 26:521-533
22. Ashizawa S, Brunicardi FC, Wang XP 2004 PDX-1 and the pancreas. Pancreas 28:109-120
23. Kaneto H, Miyatsuka T, Shiraiwa T, Yamamoto K, Kato K, Fuji-tani Y, Matsuoka TA 2007 Crucial role of PDX-1 in pancreas development, β-cell differentiation, and induction of surrogate β-cells. Curr Med Chem 14:1745-1752
24. Jonsson J, Carlsson L, Edlund T, Edlund H 1994 Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371: 606-609
25. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF 1997 Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 15:106-110
26. Ahlgren U, Jonsson J, Jonsson L, Simu K, Edlund H 1998 β-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the β-cell phenotype and maturity onset diabetes. Genes Dev 12: 1763-1768
27. Brissova M, Shiota M, Nicholson WE, Gannon M, Knobel SM, Piston DW, Wright CV, Powers AC 2002 Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion. J Biol Chem 277:11225-11232
28. Johnson JD, Ahmed NT, Luciani DS, Han Z, Tran H, Fujita J, Misler S, Edlund H, Polonsky KS 2003 Increased islet apoptosis in Pdx1+/- mice. J Clin Invest 111:1147-1160
29. Al-Quobaili F, Montenarh M 2008 Pancreatic duodenal homeobox factor-1 and diabetes mellitus type 2 (review). Int J Mol Med 21: 399-404
30. Leys CM, Nomura S, Rudzinski E, Kaminishi M, Montgomery E, Washington MK, Goldenring JR 2006 Expression of PDX-1 in human gastric metaplasia and gastric adenocarcinoma. Hum Pathol 37:1162-1168
31. Sakai H, Eishi Y, Li XL, Akiyama Y, Miyake S, Takizawa T, Koni-shi N, Tatematsu M, Koike M, Yuasa Y 2004 PDX-1 homeobox protein expression in pseudopyloric glands and gastric carcinomas. Gut 53:323-330
32. Miyatsuka T, Kaneto H, Shiraiwa T, Matsuoka TA, Yamamoto K, Kato K, Nakamura Y, Akira S, Takeda K, Kajimoto Y, Yamasaki Y, Sandgren EP, Kawaguchi Y, Wright CV, Fujitani Y 2006 Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation. Genes Dev 20:1435-1440
33. Wang XP, Li ZJ, Magnusson J, Brunicardi FC 2005 Tissue Mi-croArray analyses of pancreatic duodenal homeobox-1 in human cancers. World J Surg 29:334-338
34. Jonmarker S, Glaessgen A, Culp WD, Pisa P, Lewensohn R, Ekman P, Valdman A, Egevad L 2008 Expression of PDX-1 in prostate cancer, prostatic intraepithelial neoplasia and benign prostatic tissue. APMIS 116:491-498
35. Koizumi M, Doi R, Toyoda E, Masui T, Tulachan SS, Kawaguchi Y, Fujimoto K, Gittes GK, Imamura M 2003 Increased PDX-1 expression is associated with outcome in patients with pancreatic cancer. Surgery 134:260-266
36. Liu T, Gou SM, Wang CY, Wu HS, Xiong JX, Zhou F 2007 Pancreas duodenal homeobox-1 expression and significance in pancreatic cancer. World J Gastroenterol 13:2615-2618
37. Liu S, Rao D, Nemunaitis J, Senzer N, Dawson D, Gingras MC, Wang Z, Gibbs R, Norman M, Templeton N, DeMayo F, Stehling K, Fisher W, Brunicardi FC 22 June 2011 A novel therapeutic strategy for pancreatic neoplasia using a novel RNAi platform targeting PDX-1. Nat Proc 10101/npre.2011.6047.1
38. Gidekel Friedlander SY, Chu GC, Snyder EL, Girnius N, Dibelius G, Crowley D, Vasile E, DePinho RA, Jacks T 2009 Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras. Cancer Cell 16:379-389
39. Liu SH, Patel S, Gingras MC, Nemunaitis J, Zhou G, Chen C, Li M, Fisher W, Gibbs R, Brunicardi FC 2011 PDX-1: demonstration of oncogenic properties in pancreatic cancer. Cancer 117:723-733
40. Zhou G, Gingras MC, Liu SH, Li D, Li Z, Catania RL, Stehling KM., Li M, Paganelli G, Gibbs RA, Demayo FJ, Fisher WE, Brunicardi FC 2011 The hypofunctional effect of P335L single nucleotide polymorphism on SSTR5 function. World J Surg 35:1715-1724
41. Li Y, Cao X, Li LX, Brubaker PL, Edlund H, Drucker DJ 2005 J β-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1. Diabetes 54:482-491
42. Movassat J, Beattie GM, Lopez AD, Hayek A 2002 Exendin 4 up-regulates expression of PDX 1 and hastens differentiation and maturation of human fetal pancreatic cells. J Clin Endocrinol Metab 87:4775-4781
43. Tirone TA, Norman MA, Moldovan S, DeMayo FJ, Wang XP, Brunicardi FC 2003 Pancreatic somatostatin inhibits insulin secretion via SSTR-5 in the isolated perfused mouse pancreas model. Pancreas 26:e67-e73
44. Fujitani Y, Fujitani S, Boyer DF, Gannon M, Kawaguchi Y, Ray M, Shiota M, Stein RW, Magnuson MA, Wright CV 2006 Targeted deletion of a cis-regulatory region reveals differential gene dosage requirements for Pdx1 in foregut organ differentiation and pancreas formation. Genes Dev 20:253-266
45. Wu KL, Gannon M, Peshavaria M, Offield MF, Henderson E, Ray M, Marks A, Gamer LW, Wright CV, Stein R 1997 Hepatocyte nuclear factor 3β is involved in pancreatic β-cell-specific transcription of the pdx-1 gene. Mol Cell Biol 17:6002-6013
46. Gao N, LeLay J, Vatamaniuk MZ, Rieck S, Friedman JR, Kaestner KH 2008 Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development. Genes Dev 22:3435-3448
47. Boucher MJ, Selander L, Carlsson L, Edlund H 2006 Phosphory-lation marks IPF1/PDX1 protein for degradation by glycogen syn-thase kinase 3-dependent mechanisms. J Biol Chem 281:6395-6403
48. Humphrey RK, Yu SM, Flores LE, Jhala US 2010 Glucose regulates steady-state levels of PDX1 via the reciprocal actions of GSK3 and AKT kinases. J Biol Chem 285:3406-3416
49. Lebrun P, Montminy MR, Van Obberghen E 2005 Regulation of the pancreatic duodenal homeobox-1 protein by DNA-dependent protein kinase. J Biol Chem 280:38203-38210
50. Kishi A, Nakamura T, Nishio Y, Maegawa H, Kashiwagi A 2003 Sumoylation of Pdx1 is associated with its nuclear localization and insulin gene activation. Am J Physiol Endocrinol Metab 284:E830-E840
51. Wang XP, Norman M, Yang J, Liu SH, Magnusson J, DeMayo FJ, Brunicardi FC 2005 The effect ofglobal SSTR5 gene ablation on the endocrine pancreas and glucose regulation in aging mice. J Surg Res 129:64-72
52. Wang XP, Norman MA, Yang J, Cheung A, Moldovan S, Demayo FJ, Brunicardi FC 2004 Double-gene ablationof SSTR1 and SSTR5 results in hyperinsulinemia and improved glucose tolerance in mice. Surgery 136:585-592
53. Wang XP, Yang J, Norman MA, Magnusson J, DeMayo FJ, Bru-nicardi FC 2005 SSTR5 ablation in islet results in alterations in glucose homeostasis in mice. FEBS Lett 579:3107-3114
54. DeMartino MC, Hofland LJ, LambertsSW2010 Somatostatin and somatostatin receptors: from basic concepts to clinical applications. Prog Brain Res 182:255-280
55. Kaltsas GA, Papadogias D, Makras P, Grossman AB 2005 Treatment of advanced neuroendocrine tumours with radiolabelled so-matostatin analogues. Endocr Relat Cancer 12:683-699
56. Zhou G, Gingras MC, Liu SH, Sanchez R, Edwards D, Dawson D, Christensen K, Paganelli G, Gibbs R, Fisher W, Brunicardi FC 2011 SSTR5 P335L monoclonal antibody differentiates pancreatic neu-roendocrine neuroplasms with different SSTR5 genotypes. Surgery 150:1136-1142
57. Todisco A, Campbell V, Dickinson CJ, DelValle J, Yamada T 1994 Molecular basis for somatostatin action: inhibition of c-fos expression and AP-1 binding. Am J Physiol 267:G245-G253
58. Todisco A, Seva C, Takeuchi Y, Dickinson CJ, Yamada T 1995 Somatostatin inhibits AP-1 function via multiple protein phospha-tases. Am J Physiol 269:G160-G166
59. Grant M, Alturaihi H, Jaquet P, Collier B, Kumar U 2008 Cell growth inhibition and functioning of human somatostatin receptor type 2 are modulated by receptor heterodimerization. Mol Endo-crinol 22:2278-2292
60. Feanny MA, Fagan SP, Ballian N, Liu SH, Li Z, Wang X, Fisher W, Brunicardi FC, Belaguli NS 2008 PDX-1 expression is associated with islet proliferation in vitro and in vivo. J Surg Res 144:8-16
61. Buteau J, Roduit R, Susini S, Prentki M 1999 Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in β (INS-1)-cells. Diabetologia 42:856-864
62. Wang X, Cahill CM, Pineyro MA, Zhou J, Doyle ME, Egan JM 1999 Glucagon-like peptide-1 regulates the β cell transcription factor, PDX-1, in insulinoma cells. Endocrinology 140:4904-4907
63. Stoffers DA, Kieffer TJ, Hussain MA, Drucker DJ, Bonner-Weir S, Habener JF, Egan JM 2000 Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes 49:741-748
64. Sun Y, Zhang L, Gu HF, Han W, Ren M, Wang F, Gong B, Wang L, Guo H, Xin W, Zhao J, Gao L 2008 Peroxisome proliferator-activated receptor-a regulates the expression of pancreatic/duodenal homeobox-1 in rat insulinoma (INS-1) cells and ameliorates glucose-induced insulin secretion impaired by palmitate. Endocrinology 149:662-671
65. Watanabe H, Saito H, Ueda J, Evers BM 2008 Regulation of pancreatic duct cell differentiation by phosphatidylinositol-3 kinase. Biochem Biophys Res Commun 370:33-37
66. Takeda S, Nakao A, Miyoshi K, Takagi H 1998 Gene therapy for pancreatic cancer. Semin Surg Oncol 15:57-61
67. Rafiq I, da Silva Xavier G, Hooper S, Rutter GA 2000 Glucose-stimulated preproinsulin gene expression and nuclear trans-location of pancreatic duodenum homeobox-1 require activation of phosphatidylinositol 3-kinase but not p38 MAPK/SAPK2. J Biol Chem 275:15977-15984
68. Furukawa N, Shirotani T, Araki E, Kaneko K, Todaka M, Matsu-moto K, Tsuruzoe K, Motoshima H, Yoshizato K, Kishikawa H, Shichiri M 1999 Possible involvement of atypical protein kinase C (PKC) in glucose-sensitive expression of the human insulin gene: DNA-binding activity and transcriptional activity of pancreatic and duodenal homeobox gene-1 (PDX-1) are enhanced via calphostin C-sensitive but phorbol 12-myristate 13-acetate (PMA) and Go 6976-insensitive pathway. Endocr J 46:43-58
69. Kawamori D, Kaneto H, Nakatani Y, Matsuoka TA, Matsuhisa M, Hori M, Yamasaki Y 2006 The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation. J Biol Chem 281: 1091-1098
70. Liu S, Ballian N, Belaguli NS, Patel S, Li M, Templeton NS, Gingras MC, Gibbs R, Fisher W, Brunicardi FC 2008 PDX-1 acts as a potential molecular target for treatment of human pancreatic cancer. Pancreas 37:210-220
71. Zhou G, Boomer JS, Tan TH 2004 Protein phosphatase 4 is a positive regulator of hematopoietic progenitor kinase 1. J Biol Chem 279:49551-49561